The interstitial cells of Cajal associated with the myenteric plexus (ICC-MP) are located in the same area as the myenteric plexus. ICC-MP networks are linked to the generation of electrical pacemaker activity that causes spontaneous gastrointestinal (GI) contractions; however, its role in GI transit is not clear. The aim of this study was to comprehensively investigate the effect of ICC-MP disruption on GI transit in vivo using W/Wv mice, partially ICC-deficient model mice. In this study, we measured GI transit using a 13C-octanoic acid breath test, an orally administered dye and a bead expulsion assay. ICC were detected by immunohistochemical staining for c-Kit, a specific marker for ICC. Interestingly, we found that gastric emptying in W/Wv mice was normal. We also found that the ability of small intestinal and colonic transit was significantly reduced in W/Wv mice. Immunohistochemical staining using whole-mount muscularis samples revealed that c-Kit-positive ICC-MP networks were formed in wild-type mice. In contrast, ICC-MP networks in W/Wv mice were maintained only in the gastric antrum and were significantly reduced in the ileum and colon. No significant changes were observed in the nerve structures of the myenteric plexus in W/Wv mice. These findings suggest that ICC-MP contribute to GI transit as a powerful driving function in vivo.
Gastric emptying (GE) can be either delayed or accelerated in diabetes mellitus (DM). However, most research has focused on delayed GE mediated by a chronic hyperglycemic condition in DM. As such, the function of GE in the early stages of DM is not well understood. Interstitial cells of Cajal (ICC) are pacemaker cells in the gastrointestinal tract. In the present study, we investigated changes in GE and ICC networks in the early stages of DM using a streptozotocin-induced type 1 diabetic mouse model. The changes in GE were measured by the 13C-octanoic acid breath test. ICC networks were immunohistochemically detected by an antibody for c-Kit, a specific marker for ICC. Our results showed that GE in type 1 DM was significantly accelerated in the early stages of DM (2–4 weeks after onset). In addition, acute normalization of blood glucose levels by a single administration of insulin did not recover normal GE. ICC networks of the gastric antrum were significantly increased in DM and were not affected by the acute normalization of blood glucose. In conclusion, our results suggest that GE is accelerated in the early stages of DM, and it is associated with increased ICC networks. This mechanism may help to clarify a link between the onset of DM and GE disorders.
<b><i>Introduction:</i></b> The serotonin 3A receptor (5-HT<sub>3A</sub>R) is involved in vomiting and gastrointestinal motility. However, it is not well understood the expression pattern of 5-HT<sub>3A</sub>R in the gut immunohistochemically and how much contribution of 5-HT<sub>3A</sub>R to upper or lower intestinal motility. <b><i>Objectives:</i></b> We investigated the contribution of 5-HT<sub>3A</sub>R to gastrointestinal motor function by using 5-HT<sub>3A</sub>R KO mice and sought to identify 5-HT<sub>3A</sub>R-expressing cells via immunohistochemical staining using 5-HT<sub>3A</sub>R-GFP reporter mice. <b><i>Methods:</i></b> The expression of 5-HT<sub>3A</sub>R was measured in each section of the gut through real-time PCR. The motor function of the stomach and colon was assessed via the <sup>13</sup>C-octanoic acid breath test and colonic bead expulsion test, respectively, using 5-HT<sub>3A</sub>R KO mice. 5-HT<sub>3A</sub>R-expressing cells in the muscle layer of the gut were identified by immunohistochemical staining using 5-HT<sub>3A</sub>R-GFP reporter mice. <b><i>Results:</i></b> 5-HT<sub>3A</sub>R was expressed throughout the digestive tract, and 5-HT<sub>3A</sub>R expression in the stomach and lower digestive tract was higher than that in the other sections. Motor function in the stomach and colon was lower in 5-HT<sub>3A</sub>R KO mice than in WT mice. As a result of immunohistochemical staining using GFP reporter mice, cholinergic neurons and PDGFRα<sup>+</sup> cells were shown to express 5-HT<sub>3A</sub>R. In contrast, 5-HT<sub>3A</sub>R indicated by GFP fluorescence was rarely detected in ICC and smooth muscle cells. <b><i>Conclusions:</i></b> These results show that 5-HT<sub>3A</sub>R is highly expressed in the stomach and large intestine and that the activation of 5-HT<sub>3A</sub>R accelerates gastric emptying and large intestine transit. Additionally, 5-HT<sub>3A</sub>R is highly expressed in cholinergic neurons and some interstitial cells, such as PDGFRα<sup>+</sup> cells.
Tracking metabolic changes in skeletal muscle and bone using animal models of diabetes mellitus (DM) provides important insights for the management of DM complications. In this study, we aimed to establish a method for monitoring changes in body composition characteristics, such as fat mass, skeletal muscle mass (lean mass), bone mineral density, and bone mineral content, during DM progression using a dual-energy X-ray absorptiometry (DXA) system in a mouse model of streptozotocin (STZ)-induced type 1 DM. In the DM model, STZ administration resulted in increased blood glucose levels, increased water and food intake, and decreased body weight. Serum insulin levels were significantly decreased on day 30 of STZ administration. The DXA analysis revealed significant and persistent decreases in fat mass, lower limb skeletal muscle mass, and bone mineral content in DM mice. We measured tibialis anterior (TA) muscle weight and performed a quantitative analysis of tibial microstructure by micro-computed tomography imaging in DM mice. The TA muscle weight of DM mice was significantly lower than that of control mice. In addition, the trabecular bone volume fraction, trabecular thickness, trabecular number, and cortical thickness were significantly decreased in DM mice. Pearson’s product-moment correlation coefficient analysis showed a high correlation between the DXA-measured and actual body composition. In conclusion, longitudinal measurement of body composition changes using a DXA system may be useful for monitoring abnormalities in muscle and bone metabolism in animal models of metabolic diseases such as DM mice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.